Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$410,000 |
 |
Gilead SciencesGILD |
-$1.03B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$98M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Joyce Meghan V. | Sep 2, 2025 | Sell | 100 | $65.84 | $6,600 |
| Kalia Kumud | Aug 21, 2025 | Sell | 2,000 | $61.755 | $120,000 |
| Tariq Musa | Aug 19, 2025 | Sell | 116 | $59.02 | $6,800 |
| POTTER MYRTLE S | Aug 19, 2025 | Sell | 26 | $59.02 | $1,500 |
| Tariq Musa | Jul 17, 2025 | Sell | 116 | $48.2 | $5,600 |
| POTTER MYRTLE S | Jul 17, 2025 | Sell | 26 | $48.2 | $1,300 |
| Talasaz AmirAli | Jul 1, 2025 | Sell | 72,068 | $50.6715 | $3.7M |
| Talasaz AmirAli | Jul 1, 2025 | Sell | 27,932 | $51.4047 | $1.4M |
| Tariq Musa | Jun 18, 2025 | Sell | 3,213 | $49.47 | $160,000 |
| POTTER MYRTLE S | Jun 18, 2025 | Sell | 26 | $49.47 | $1,300 |
| CLARK IAN T | Jun 17, 2025 | Sell | 6,672 | $48.3841 | $320,000 |
| POTTER MYRTLE S | Jun 16, 2025 | Sell | 2,626 | $49.7 | $130,000 |
| Joyce Meghan V. | Jun 13, 2025 | Sell | 3,337 | $47.22 | $160,000 |
| Talasaz AmirAli | Jun 9, 2025 | Sell | 77,853 | $50.0936 | $3.9M |
| Talasaz AmirAli | Jun 6, 2025 | Sell | 39,751 | $50.0722 | $2M |
| Talasaz AmirAli | Jun 5, 2025 | Sell | 1,680 | $50.0041 | $84,000 |
| Kalia Kumud | Jun 3, 2025 | Sell | 4,000 | $46.3904 | $190,000 |
| Joyce Meghan V. | Jun 2, 2025 | Sell | 100 | $41.66 | $4,200 |
| Tariq Musa | May 19, 2025 | Sell | 116 | $40.04 | $4,600 |
| Talasaz AmirAli | May 2, 2025 | Sell | 13,932 | $50.4702 | $700,000 |
| Talasaz AmirAli | May 1, 2025 | Sell | 44,691 | $49.5337 | $2.2M |
| Talasaz AmirAli | May 1, 2025 | Sell | 38,477 | $48.7122 | $1.9M |
| Talasaz AmirAli | May 1, 2025 | Sell | 18,069 | $47.6659 | $860,000 |
| Talasaz AmirAli | May 1, 2025 | Sell | 3,445 | $50.9128 | $180,000 |
| Talasaz AmirAli | May 1, 2025 | Sell | 1,748 | $51.5622 | $90,000 |
| Talasaz AmirAli | May 1, 2025 | Sell | 354 | $52.5729 | $19,000 |
| Tariq Musa | Apr 17, 2025 | Sell | 116 | $44.79 | $5,200 |
| Tariq Musa | Mar 19, 2025 | Sell | 116 | $43.7 | $5,100 |
| Kalia Kumud | Mar 17, 2025 | Sell | 3,500 | $43.1601 | $150,000 |
| Joyce Meghan V. | Mar 3, 2025 | Sell | 100 | $42.71 | $4,300 |
| Tariq Musa | Feb 20, 2025 | Sell | 116 | $48.33 | $5,600 |
| Tariq Musa | Jan 17, 2025 | Sell | 116 | $37.58 | $4,400 |
| Tariq Musa | Dec 18, 2024 | Sell | 116 | $34.85 | $4,000 |
| Tariq Musa | Dec 13, 2024 | Sell | 2,320 | $35 | $81,000 |
| Joyce Meghan V. | Dec 2, 2024 | Sell | 100 | $35.9 | $3,600 |
| Kalia Kumud | Nov 18, 2024 | Sell | 7,000 | $29.246 | $200,000 |
| Joyce Meghan V. | Nov 13, 2024 | Sell | 2,896 | $29.9017 | $87,000 |
| CLARK IAN T | Nov 12, 2024 | Sell | 7,242 | $29.4351 | $210,000 |
| CLARK IAN T | Nov 12, 2024 | Sell | 1,076 | $29.5172 | $32,000 |
| Joyce Meghan V. | Jun 4, 2024 | Sell | 100 | $27.87 | $2,800 |
| Kalia Kumud | Mar 18, 2024 | Buy | 2,187 | $17.8156 | $39,000 |
| Joyce Meghan V. | Mar 4, 2024 | Sell | 100 | $19.05 | $1,900 |
| Joyce Meghan V. | Dec 4, 2023 | Sell | 100 | $26.34 | $2,600 |
| Kalia Kumud | Dec 1, 2023 | Sell | 5,800 | $26.3714 | $150,000 |
| Kalia Kumud | Sep 12, 2023 | Sell | 2,125 | $32.59 | $69,000 |
What's the latest insider transaction for Guardant Health?
The most recent insider transaction for Guardant Health was conducted by Joyce Meghan V., who sold 100 shares on September 2, 2025 at a price of $65.84 per share.
Which insider bought the most GH stock over the last two years?
Kalia Kumud has bought the most GH stock in the last 2 years, with a total value of $39,000.
Which insider has sold the most GH stock over the last two years?
Talasaz AmirAli has sold the most GH stock in the last 2 years, with a total value of $17M.
What is the total value of insider transactions for Guardant Health (GH) in the last 2 years?
The total value of insider transactions for Guardant Health in the last 2 years is negative, amounting to -$19M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Guardant Health's market confidence?
Over the last 2 years, insider transactions for Guardant Health have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
